Lessons from Past U.S. Global Health Agreements Under Trump

Feb 14, 2026, 2:45 AM
Image for article Lessons from Past U.S. Global Health Agreements Under Trump

Hover over text to view sources

The Trump administration has initiated a sweeping reconfiguration of US global health agreements, shifting the focus towards direct partnerships with low-income countries while significantly reducing reliance on international aid organizations. This transition raises questions about past strategies in government-to-government assistance and the potential implications for global health initiatives.
Beginning in 2025, the Trump administration proposed a new strategy to reshape global health assistance, emphasizing a reduction in the "culture of dependency" associated with traditional aid models. The administration's plan aims to establish direct agreements with recipient countries, fostering ownership and accountability in health initiatives. This approach marks a departure from previous practices where funding was predominantly channeled through international organizations, such as the World Health Organization (WHO), which the US formally withdrew from, citing inefficiency concerns.
One of the administration's significant actions was the announcement of the America First Global Health Strategy, which prioritizes health service support while cutting funding for various global health activities deemed non-essential. The new strategy aims to streamline programs and integrate services, moving away from disease-specific initiatives towards a more unified health system. The intent is to enhance the effectiveness of US funding and support while also encouraging recipient countries to assume greater responsibility for their health systems.
The proposed strategy has been met with mixed reactions. Supporters argue that empowering local governments can lead to sustainable health outcomes, reducing reliance on external assistance. Critics, however, caution that the abrupt withdrawal from established aid frameworks could undermine health systems that have taken years to build. They emphasize that without adequate oversight and technical support, the transition could jeopardize progress in combating diseases like HIV/AIDS and maternal health issues, which have historically benefitted from US funding and expertise.
The Trump administration's approach reflects lessons learned from previous government-to-government assistance models. Historically, direct partnerships have been effective in certain contexts, particularly when local governments are committed to contributing financially and managing programs. However, past experiences also highlight challenges, such as inconsistent government accountability and insufficient local capacity to manage complex health initiatives.
Additionally, the administration's stance on foreign aid has been characterized by significant funding cuts, particularly to programs related to sexual and reproductive health, raising concerns about the broader impacts on global health services. The decision to terminate funding for family planning and maternal health programs has sparked debate about the long-term consequences for public health in low-income countries, where access to these services is already limited.
As the Trump administration moves forward with its global health strategy, it is essential to consider the implications of these changes. The focus on direct government partnerships could foster innovation and accountability, but it also risks sidelining critical health needs and expertise from non-governmental organizations (NGOs) that have historically played a vital role in delivering health services.
In conclusion, while the Trump administration’s strategy aims to promote self-reliance and efficiency in global health, its success will depend on balancing local ownership with the necessary support and resources to address public health challenges effectively. Drawing lessons from past experiences in government-to-government assistance can guide future efforts to ensure that health systems in low-income countries remain robust and capable of meeting the needs of their populations.

Related articles

Trump Administration Cuts Drug Prices for GLP-1 and Fertility Medications

The Trump administration's recent initiatives have led to significant reductions in drug prices, particularly for GLP-1 medications and fertility treatments. Medicare Director Chris Klomp noted that these changes aim to improve affordability for many Americans, allowing easier access to essential medications.

State Legislation to Enhance Medicaid Mental Health Support

State legislation is increasingly focusing on enhancing mental health support through Medicaid, recognizing the importance of trauma-informed care. By incorporating new policies and funding initiatives, states aim to improve access to mental health services, especially for vulnerable populations.

Mississippi's Dr. Daniel Edney Considered for CDC Directorship

Dr Daniel Edney, Mississippi's state health officer, is under consideration to lead the CDC as its new director amid a national debate on public health roles. Known for championing immunization and improving health outcomes in Mississippi, Edney's potential appointment comes as the current director's interim term nears its end.

Acting CDC Director Jay Bhattacharya Advocates for Measles Vaccination

Acting CDC Director Jay Bhattacharya has called for increased vaccination against measles as outbreaks rise across the US He emphasized the importance of the MMR vaccine, which he described as the most effective means of prevention. With over 1,100 cases reported this year, the CDC is mobilizing resources to address the situation.

Navigating Trump Administration's Health Care Policy in New York

The Trump Administration has initiated significant changes in healthcare policy that impact New York's health landscape. Key reforms focus on interoperability and the integration of technology in health services, aiming to enhance patient care while navigating the complexities of federal funding and regulation.